Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT
Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT
Recruiting · NCT03793517 · Registry updated 2020-03-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 / Phase 3 | 2020-03-10 | NCT03793517 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University People's Hospital | 269 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University Institute of Hematology,Beijing | Beijing | China | 1 |